Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.

ClinicalTrials.gov ID: NCT00055510

Public ClinicalTrials.gov record NCT00055510. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00055510
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Chugai Pharma USA
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

United States locations

U.S. sites
29
U.S. states
17
U.S. cities
27
Facility City State ZIP Site status
St. Luke's Medical Center Phoenix Arizona 85006
University of Arizona Sarver Heart Center Tucson Arizona 85724
Cardiovascular Associates of the Peninsula Burlingame California 94010
Foundation for Cardiovascular Medicine La Jolla California 92037
La Mesa Cardiac Center La Mesa California 91942
Clinical Research Center of California San Diego California 92117
Veterans Affairs Medical Center San Diego California 92161
University of Florida Health Science Center Jacksonville Florida 32209
Miami International Cardiology Consultants Miami Beach Florida 33140
Mediquest Research Group Ocala Florida 34474
Midwest Heart Research Foundation Lombard Illinois 60148
Iowa Heart Center Des Moines Iowa 50314
Alton Ochsner Medical Foundation New Orleans Louisiana 70121
Brigham and Women's Hospital Boston Massachusetts 02115
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Baystate Medical Center Springfield Massachusetts 01199
Borgess Medical Center Kalamazoo Michigan 49048
Michigan Heart Ypsilanti Michigan 48197
Minneapolis Heart Institute Foundation Minneapolis Minnesota 55407
St. Louis University St Louis Missouri 63110
Nevada Cardiology Associates Las Vegas Nevada 89109
University of Rochester Medical Center Rochester New York 14642
Asheville Cardiology Associates, PA Asheville North Carolina 28803
Northwestern Memorial Hospital Elyria Ohio 44035
Oklahoma Foundation for Cardiovascular Research Oklahoma City Oklahoma 73120
Austin Heart Austin Texas 78756
IRCI Institute for Research in Cardiovascular Interventions at The Methodist DeBakey Heart Center Houston Texas 77030
University of Texas Health Science Center San Antonio Texas 78229-3900
University of Utah Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00055510, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00055510 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →